When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Which Medications Are FDA-Approved for Weight Loss? - AOL

   www.aol.com/medications-fda-approved-weight-loss...

   Qsymia (Phentermine-Topiramate) Qsymia is a once-daily oral weight loss medication approved for adults and adolescents 12 years and older who meet the BMI criteria. This medicine works on ...

3. FDA approves new version of diabetes drug Mounjaro for weight ...

   www.aol.com/fda-approves-version-diabetes-drug...

   This image provided by Eli Lilly on Wednesday, Nov. 8, 2023 shows packaging for their new drug Zepbound. The new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss ...

4. Anti-obesity medication - Wikipedia

   en.wikipedia.org/wiki/Anti-obesity_medication

   t. e. Orlistat (Xenical), the most commonly used medication to treat obesity and sibutramine (Meridia), a medication that was withdrawn due to cardiovascular side effects. Anti-obesity medication or weight loss medications are pharmacological agents that reduce or control excess body fat. These medications alter one of the fundamental processes ...

5. Tirzepatide - Wikipedia

   en.wikipedia.org/wiki/Tirzepatide

   Tirzepatide is an antidiabetic medication used for the treatment of type 2 diabetes [10][13][14][15] and for weight loss. [11][16] Tirzepatide is administered via subcutaneous injections (under the skin). [10][13] It is sold under the brand names Mounjaro for diabetes treatment, [10] and Zepbound for weight loss. [11]

6. 15 Alternatives to Ozempic for Weight Loss - AOL

   www.aol.com/15-alternatives-ozempic-weight-loss...

   Zepbound. For another Ozempic-like drug for weight loss, consider Zepbound, Mounjaro’s weight loss counterpart. Zepbound is another brand name for tirzepatide. It comes in the same doses as ...

7. Tesofensine - Wikipedia

   en.wikipedia.org/wiki/Tesofensine

   The placebo-subtracted mean weight losses were 4.5%, 9.2% and 10.6% in the 0.25 mg, 0.5 mg and 1 mg dose groups, respectively. This is approximately twice the weight loss produced by medications currently approved by the US Food and Drug Administration (FDA) for the treatment of obesity.